by Stacey Hawkins | Nov 5, 2019 | Genetic Disease
A Breath of fresh air for cystic fibrosis patients It’s not often that a radical treatment for a chronic, often fatal, disease comes around. The WEEKLY takes notice when one does. Vertex Pharmaceuticals’ (Boston, MA) innovative new drug, Trikafta, promises better... 
by Stacey Hawkins | Jul 9, 2015 | Uncategorized
Biotech Changes The Game The FDA approval of Vertex Pharmaceutical’s (Boston, MA) Orkambi last week further shifted the paradigm of treating cystic fibrosis (CF) for up to half of its sufferers—moving from a management of symptoms approach to targeting the underlying...
